Click on image to view larger version.

Figure 3 Changes of endothelin-1 plasma levels after administration of various dosages of the selective ET_A receptor antagonist LU135252. There was a dose-dependent increase in plasma ET-1 levels. *p < 0.003 vs. baseline.